You are here

Lipella Pharmaceuticals Inc.

Company Information
Address
7800 SUSQUEHANNA ST STE 505
PITTSBURGH, PA 15208-2156
United States



Information

UEI: JBVNWFNEEV59

# of Employees: N/A


Ownership Information

HUBZone Owned: No

Socially and Economically Disadvantaged: No

Woman Owned: No



Award Charts




Award Listing

  1. Bladder drug delivery using intravesical liposomes to treat overactive bladder

    Amount: $100,000.00

    DESCRIPTION (provided by applicant): Lipella Pharmaceutical Inc has been successful with development of intravesical liposome for painful bladder syndrome/Interstitial cystitis (PBS/IC). Through SB ...

    SBIRPhase I2009Department of Health and Human Services National Institutes of Health
  2. Developing Intravesical Liposomes for Interstitial Cystitis

    Amount: $740,688.00

    DESCRIPTION (provided by applicant): LP08 is a novel intravesical treatment for interstitial cystitis (IC), a poorly understood chronic disorder of unknown etiology consisting of irritative bladder sy ...

    STTRPhase I2009Department of Health and Human Services National Institutes of Health
  3. Intravesical Liposome Treatment for Interstitial Cystitis

    Amount: $750,000.00

    DESCRIPTION (provided by applicant): Interstitial cystitis (IC) is a chronic, severely debilitating disease of the urinary bladder. It can be described as a chronic inflammatory condition of the bladd ...

    SBIRPhase II2008Department of Health and Human Services National Institutes of Health
  4. Intravesical Liposome Treatment for Interstitial Cystitis

    Amount: $99,617.00

    DESCRIPTION (provided by applicant): Interstitial cystitis (IC) is a chronic, severely debilitating disease of the urinary bladder. It can be described as a chronic inflammatory condition of the bladd ...

    SBIRPhase I2006Department of Health and Human Services National Institutes of Health
US Flag An Official Website of the United States Government